Is There Effect of Adding Honey Intake to Free Walking in Metabolic Syndrome Children

June 14, 2024 updated by: Hagar Ahmed El-Hadidy, Ahram Canadian University

Response of Metabolic Syndrome Components to Adding Honey Consumption to Free Walking Exercise in Children

Metabolic Syndrome is common in Children and complementary therapies are important in its treatment such exercise and functional food intake including honey.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Forty Children with metabolic syndrome will Assigned to group of free walking continuous exercise (thirty minutes daily in nearby sport club in the presence of their parents and walking was supervised by authors via Videoconferencing Imo Program) and this group also will receive healthy dietary guidelines in addition to consuming natural honey for 12 weeks.. The other group that will contain 20 patients will take only free walking exercise and healthy diet guidelines for 12 weeks.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 40 metabolic syndrome children

Exclusion Criteria:

  • respiratory, cardiac , renal , liver problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Honey intake with walking exercise
20 Children with metabolic syndrome will receive free walking continuous exercise (thirty minutes daily in nearby sport club in the presence of their parents and walking will supervised by authors via Videoconferencing Imo Program) and this group also will healthy diet guidelines in addition to consuming natural honey (2ml/kg honey will be taken.. This dose will be divided into two halves, the first half will be taken at 7 am and the other half will be taken at 7 pm for 12 weeks)
Behavioral: Honey intake with walking exercise
20 Children with metabolic syndrome will receive free walking continuous exercise (thirty minutes daily in nearby sport club in the presence of their parents and walking will supervised by authors via Videoconferencing Imo Program) and this group also will healthy diet guidelines in addition to consuming natural honey (2ml/kg honey will be taken.. This dose will be divided into two halves, the first half will be taken at 7 am and the other half will be taken at 7 pm for 12 weeks)
Active Comparator: walking exercise
20 Children with metabolic syndrome will receive free walking continuous exercise (thirty minutes daily in nearby sport club in the presence of their parents and walking will supervised by authors via Videoconferencing Imo Program) and this group also will healthy diet guidelines for 12 weeks
Behavioral: Walking exercise
20 Children with metabolic syndrome will receive free walking continuous exercise (thirty minutes daily in nearby sport club in the presence of their parents and walking will supervised by authors via Videoconferencing Imo Program) and this group also will healthy diet guidelines for 12 weeks)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
high density lipoprotein
Time Frame: it will be assessed after 12 weeks
it is a component of lipid profile
it will be assessed after 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
triglycrides
Time Frame: it will be assessed after 12 weeks
it is a component of lipid profile
it will be assessed after 12 weeks
body mass index
Time Frame: it will be assessed after 12 weeks
it will be measured in morning with empty stomach and badder
it will be assessed after 12 weeks
waist circumference
Time Frame: it will be assessed after 12 weeks
it will be measured by a tape at the level of umblicus
it will be assessed after 12 weeks
systolic blood pressure
Time Frame: it will be assessed after 12 weeks
it will be measured by manual sphygomamnaometer
it will be assessed after 12 weeks
diastolic blood pressure
Time Frame: it will be assessed after 12 weeks
it will be measured by manual sphygomamnaometer
it will be assessed after 12 weeks
fasting blood glucose
Time Frame: it will be assessed after 12 weeks
it will be measured at morning
it will be assessed after 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ahram Canadian University

Investigators

  • Principal Investigator: hagar el-hadidy, lecturer, Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2024

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

October 1, 2024

Study Registration Dates

First Submitted

June 14, 2024

First Submitted That Met QC Criteria

June 14, 2024

First Posted (Actual)

June 20, 2024

Study Record Updates

Last Update Posted (Actual)

June 20, 2024

Last Update Submitted That Met QC Criteria

June 14, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T -PED-06/2024- 545

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on Honey intake with walking exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe